Characterization of the in vitro phosphorylation of human tau by tau protein kinase II (cdk5/p20) using mass spectrometry

被引:62
作者
Lund, ET
McKenna, R
Evans, DB
Sharma, SK
Mathews, WR
机构
[1] Pharmacia Corp, Struct Analyt & Med Chem, Kalamazoo, MI 49007 USA
[2] Pharmacia Corp, Prot Sci, Kalamazoo, MI USA
关键词
Alzheimer's disease; mass spectrometry; phosphorylation; tau protein kinase II; tau;
D O I
10.1046/j.1471-4159.2001.00130.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperphosphorylated tau is an integral part of the neurofibrillary tangles that form within neuronal cell bodies, acid tau protein kinase II is reported to play a role in the pathogenesis of Alzheimer's disease. Recently, we reported that tau protein kinase II (cdk5/p20)-phosphorylated human tau inhibits microtubule assembly, and tau protein kinase II (cdk5/p20) phosphorylation of microtubule-associated tau results in dissociation of phosphorylated tau from the microtubules and tubulin depolymerization. In the studies reported here, a combination of mass spectrometric techniques was used to study the phosphorylation of human recombinant tau by recombinant tau protein kinase II (cdk5/p20) in vitro. The extent of phosphorylation was determined by measuring the molecular mass of phosphorylated tau using mass spectrometry. Reaction of human recombinant tau with tau protein kinase II (cdk5/p20) resulted in the formation of two major species containing either five or six phosphate groups. The specific amino acid residues phosphorylated were determined by analyzing tryptic peptides by tandem mass spectrometry via either MALDI/TOF post-source decay or by electrospray tandem mass spectrometry. Based on these experiments, we conclude that tau protein kinase II (cdk5/p20) can phosphorylate human tau at Thr(181), Thr(205), Thr(212), Thr(217), Ser(396) and Ser(404).
引用
收藏
页码:1221 / 1232
页数:12
相关论文
共 33 条
[1]   Hyperphosphorylated tan and neurofilament and cytoskeletal disruptions in mice overexpressing human p25, an activator of cdk5 [J].
Ahlijanian, MK ;
Barrezueta, NX ;
Williams, RD ;
Jakowski, A ;
Kowsz, KP ;
McCarthy, S ;
Coskran, T ;
Carlo, A ;
Seymour, PA ;
Burkhardt, JE ;
Nelson, RB ;
McNeish, JD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) :2910-2915
[2]   Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules [J].
Alonso, AD ;
GrundkeIqbal, I ;
Iqbal, K .
NATURE MEDICINE, 1996, 2 (07) :783-787
[3]   A PROCEDURE FOR INSITU ALKYLATION OF CYSTINE RESIDUES ON GLASS-FIBER PRIOR TO PROTEIN MICROSEQUENCE ANALYSIS [J].
ANDREWS, PC ;
DIXON, JE .
ANALYTICAL BIOCHEMISTRY, 1987, 161 (02) :524-528
[4]   TAU-PROTEIN KINASE-II IS INVOLVED IN THE REGULATION OF THE NORMAL PHOSPHORYLATION STATE OF TAU-PROTEIN [J].
ARIOKA, M ;
TSUKAMOTO, M ;
ISHIGURO, K ;
KATO, R ;
SATO, K ;
IMAHORI, K ;
UCHIDA, T .
JOURNAL OF NEUROCHEMISTRY, 1993, 60 (02) :461-468
[5]   ACCUMULATION OF ABNORMALLY PHOSPHORYLATED-TAU PRECEDES THE FORMATION OF NEUROFIBRILLARY TANGLES IN ALZHEIMERS-DISEASE [J].
BANCHER, C ;
BRUNNER, C ;
LASSMANN, H ;
BUDKA, H ;
JELLINGER, K ;
WICHE, G ;
SEITELBERGER, F ;
GRUNDKEIQBAL, I ;
IQBAL, K ;
WISNIEWSKI, HM .
BRAIN RESEARCH, 1989, 477 (1-2) :90-99
[6]   CONTRIBUTIONS OF MASS-SPECTROMETRY TO PEPTIDE AND PROTEIN-STRUCTURE [J].
BIEMANN, K .
BIOMEDICAL AND ENVIRONMENTAL MASS SPECTROMETRY, 1988, 16 (1-12) :99-111
[7]  
BONDAREFF W, 1990, AM J PATHOL, V137, P711
[8]   TAU-PROTEIN FUNCTION IN LIVING CELLS [J].
DRUBIN, DG ;
KIRSCHNER, MW .
JOURNAL OF CELL BIOLOGY, 1986, 103 (06) :2739-2746
[9]   Tau phosphorylation at serine 396 and serine 404 by human recombinant tau protein kinase II inhibits tau's ability to promote microtubule assembly [J].
Evans, DB ;
Rank, KB ;
Bhattacharya, K ;
Thomsen, DR ;
Gurney, ME ;
Sharma, SK .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (32) :24977-24983
[10]   TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE [J].
GOEDERT, M .
TRENDS IN NEUROSCIENCES, 1993, 16 (11) :460-465